Clinical Trials on Papulopustular Rosacea (PPR) in Canada
Total 28 results
-
Galderma R&DCompleted
-
Tarsus Pharmaceuticals, Inc.Active, not recruiting
-
Galderma R&DCompleted
-
Ulthera, IncCompletedErythematotelangiectatic RosaceaCanada
-
Ulthera, IncCompletedRosacea | Erythematotelangiectatic RosaceaUnited States, Canada
-
Galderma R&DChiltern International Inc.Completed
-
Innovaderm Research Inc.Completed
-
Dermira, Inc.Completed
-
Galderma R&DCompleted
-
Express CollaborativeCompleted
-
Ottawa Hospital Research InstituteCanadian Frailty Network; The Ottawa Hospital Academic Medical AssociationCompleted
-
Galderma R&DCompletedRosaceaUnited States, Canada, Hungary
-
Galderma R&DCompletedRosaceaUnited States, Canada
-
Maruho Co., Ltd.CompletedRosaceaUnited States, France, United Kingdom, Germany, Canada, Netherlands, New Zealand, Australia, Sweden
-
Maruho Co., Ltd.CompletedRosaceaUnited States, United Kingdom, Canada, New Zealand, Australia, France, Sweden, Netherlands
-
Maruho Co., Ltd.CompletedRosaceaUnited States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Netherlands, Sweden
-
Galderma R&DCompletedRosaceaUnited States, Canada
-
Galderma R&DCompletedRosaceaUnited States, Canada
-
University of British ColumbiaCompletedProliferative Diabetic Retinopathy (PDR)Canada
-
Mansoura UniversityActive, not recruitingErectile Dysfunction Following Radiation Therapy | Phosphodiesterase Inhibitor Adverse Reaction | Platelet- Rich Plasma (PRP)Egypt
-
Sorin Group CanadaCompletedAny Patient Who Fulfills the Inclusion Criteria to be Implanted With a Dual Chamber Pacemaker Maybe Included in the Study as Per ACC/AHA GuidelinesCanada
-
Children's & Women's Health Centre of British ColumbiaWithdrawnObstructive Sleep Apnea (Mild, Moderate, Severe) as Per PolysomnographyCanada
-
Boehringer IngelheimCompletedPalmoplantar Pustulosis (PPP)United Kingdom, Korea, Republic of, United States, Canada, Belgium, Australia, Taiwan, Japan, France, Germany, Russian Federation, Hungary, Netherlands, Czechia, Poland
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Simon Ducharme, MDAlzheimer's Drug Discovery FoundationActive, not recruitingFrontotemporal Dementia | Primary Progressive Aphasia | Frontotemporal Dementia, Behavioral Variant | FTD | PPA | bvFTDCanada
-
VelosBio Inc.CompletedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer | Estrogen-receptor-negative... and other conditionsUnited States, Canada
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS); National Center... and other collaboratorsCompletedAmyotrophic Lateral Sclerosis (ALS) | Progressive Supranuclear Palsy (PSP) | Corticobasal Degeneration (CBD) | FTLD | Frontotemporal Dementia (FTD) | PPA Syndrome | Behavioral Variant Frontotemporal Dementia (bvFTD) | Semantic Variant Primary Progressive Aphasia (svPPA) | Nonfluent Variant Primary Progressive... and other conditionsUnited States, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States